|
Active substance |
risdiplam |
|
Holder |
Roche |
|
Status |
closed |
|
Indication |
treatment of patients who suffer from Type 1 SMA |
|
Public documents |
|
| Approbation amendment | |
|
Last update |
09/06/2022 |
Risdiplam®
Last updated on 13/09/2024